LXRβ activation is sufficient to reduce atherosclerosis [67] and may contribute [68], together with LXRα, to the favorable upregulation of Abca1 and Abcg1 expression both in vivo and in vitro. The gene discussed is NR1H2; the disease is atherosclerosis.